Comparing the current results to its competitors, Merit Medical Systems Inc reported Revenue increase in the 1 quarter 2026 by 7.54 % year on year. The sales growth was above Merit Medical Systems Inc's competitors' average revenue growth of 5.37 %, achieved in the same quarter.
Merit Medical Systems Inc Net Income in the 1 quarter 2026 grew year on year by 35.98%, faster than the Merit Medical Systems Inc's competitors average income growth of 5.91 %
Merit Medical Systems Inc's Comment on Competition and Industry Peers
The company focuses on quickly conceiving, designing, developing, and launching new products that address customer needs. In the United States, it maintains dedicated direct sales organizations targeting end-user physicians, hospitals, alternate site facilities, major buying groups, and integrated healthcare networks. Internationally, the company employs sales representatives and partners with independent distributors.
With revenue growth of 7.54 % within Overall company, Merit Medical Systems Inc achieved improvement in market share, within Overall company to approximately 0.83 %. << More on MMSI Market Share.
*Market share is calculated based on total revenue.
September 16, 2024
A Memorable : In the venerable annals of medical inquiry, under the resplendent aegis of modern innovation, our esteemed colleagues at Merit Medical have ushered forth a prodigious advancement hitherto unseen in the annals of vascular intervention. The recent WRAPSODY WAVE Trial has unfurled a tapestry of hope for those afflicted with the tribulations of arteriovenous (AV) fistulas, a condition that beseeches the guardians of health with its myriad complexities.This pivotal trial, conducted across the boundless expanse of the United States, hath yielded results of such magnitude that they compel our immediate attention and admiration. Lo and behold, the hallowed achievement of an astounding primary patency ...
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Lemaitre Vascular Inc is a medical device company specializing in the design, development, and distribution of innovative medical devices for the treatment of peripheral vascular disease. Their business model revolves around creating and manufacturing high-quality products that address specific needs in the field of vascular surgery. They leverage a combination of direct sales, distribution partnerships, and ongoing research and development efforts to effectively reach healthcare professionals and provide comprehensive solutions for patients.
Livanova Plc is a global medical technology company that focuses on developing and delivering innovative solutions for patients with cardiovascular diseases and neuropsychiatric disorders. Through their diverse portfolio, they offer products and therapies that encompass surgical heart valves, cardiac rhythm management, and neuromodulation. Livanova adopts a patient-centric approach, collaborating with healthcare professionals to improve patient outcomes and enhance quality of life.
Ir med Inc's business model involves providing innovative medical technologies and solutions to the healthcare industry. The company focuses on developing and commercializing advanced medical devices that aim to improve patient outcomes and enhance overall healthcare management.
Sources:
Merit Medical Systems Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Merit Medical Systems Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
